I agree that this site is using cookies. You can find further informations here.
X
Papp, Márk
490  results:
Search for persons X
?
1

Physiology of Zinc Oxide Nanoparticles in Plants:

, In: Plant Responses to Nanomaterials; Nanotechnology in the Life Sciences,
Szőllősi, Réka ; Molnár, Árpád ; Feigl, Gábor... - p. 95-127 , 2021
Link: https://doi.org/10.1007/..
 
?
2

Nitro-oxidative signalling induced by chemically synthetize..:

Molnár, Árpád ; Papp, Márk ; Zoltán Kovács, Dávid...
Chemosphere.  251 (2020)  - p. 126419 , 2020
Link: https://doi.org/10.1016/..
 
?
3

089. PREDICTING FRACTURES USING BONE MINERAL DENSITY AT DIF..:

Davies, Kristen ; Papp, Mark ; Bukhari, Marwan
Rheumatology.  56 (2017)  suppl_2 - p. , 2017
Link: https://doi.org/10.1093/..
 
?
4

160. FRACTURE RISK FACTORS VARY SIGNIFICANTLY DEPENDING ON ..:

Papp, Mark ; Bukhari, Marwan
Rheumatology.  56 (2017)  suppl_2 - p. , 2017
Link: https://doi.org/10.1093/..
 
?
5

097. PREDICTORS OF FRACTURES IN SMOKERS: AN OBSERVATIONAL S..:

Papp, Mark ; Sinha, Richa ; Bukhari, Marwan
Rheumatology.  56 (2017)  suppl_2 - p. , 2017
Link: https://doi.org/10.1093/..
 
?
6

Physiology of Zinc Oxide Nanoparticles in Plants:

Szőllősi Réka ; Molnár Árpád ; Feigl Gábor...
http://publicatio.bibl.u-szeged.hu/22411/1/Szllsietal_2021_PhysiologyofZnONPsinplants_Chapter.pdf.  , 2021
Link: http://publicatio.bibl.u..
 
?
7

Diabetic myocardial disorder. A clinical consensus statemen..:

Seferović, Petar M. ; Paulus, Walter J. ; Rosano, Giuseppe...
European Journal of Heart Failure.  , 2024
Link: https://doi.org/10.1002/..
 
?
8

Long-term safety of Ixekizumab in adults with psoriasis, ps..:

Deodhar, Atul ; Blauvelt, Andrew ; Lebwohl, Mark...
Arthritis Research & Therapy.  26 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
9

Efficacy of brodalumab in moderate-to-severe plaque psorias..:

Papp, Kim ; Prajapati, Vimal H. ; Maari, Catherine...
Journal of the American Academy of Dermatology.  90 (2024)  6 - p. 1254-1256 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Roflumilast Cream 0.3% in Patients With Chronic Plaque Psor..:

Del Rosso, James ; Hong, H. Chih-ho ; Kircik, Leon...
SKIN The Journal of Cutaneous Medicine.  8 (2024)  2 - p. s355 , 2024
Link: https://doi.org/10.25251..
 
?
11

Deucravacitinib in Plaque Psoriasis: 4-Year Safety and Effi..:

Armstrong, April W. ; Lebwohl, Mark ; Warren, Richard B....
SKIN The Journal of Cutaneous Medicine.  8 (2024)  4 - p. s406 , 2024
Link: https://doi.org/10.25251..
 
?
12

Deucravacitinib in Plaque Psoriasis: 3-year Safety and Effi..:

Armstrong, April W. ; Lebwohl, Mark ; Warren, Richard B....
SKIN The Journal of Cutaneous Medicine.  8 (2024)  2 - p. s366 , 2024
Link: https://doi.org/10.25251..
 
?
13

Long-term safety and effectiveness of roflumilast cream 0.3..:

Stein Gold, Linda ; Adam, David N. ; Albrecht, Lorne...
Journal of the American Academy of Dermatology.  91 (2024)  2 - p. 273-280 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Deucravacitinib in moderate‐to‐severe plaque psoriasis: Poo..:

Strober, Bruce ; Blauvelt, Andrew ; Warren, Richard B....
Journal of the European Academy of Dermatology and Venereology.  38 (2024)  8 - p. 1543-1554 , 2024
Link: https://doi.org/10.1111/..
 
?
15

Roflumilast Cream 0.3% in Patients with Chronic Plaque Psor..:

Del Rosso, James ; Hong, H. Chih-ho ; Kircik, Leon...
SKIN The Journal of Cutaneous Medicine.  8 (2024)  1 - p. s310 , 2024
Link: https://doi.org/10.25251..
 
1-15